Radiotherapy and bevacizumab for intramedullary and leptomenigeal metastatic glioblastoma: a case report and review of the literature.
Int J Neurosci. 2012 Nov;122(11):691-4
Authors: Fiorentino A, Caivano R, Chiumento C, Cozzolino M, Fusco V
Glioblastoma (GBM) developed metastases rarely and the prognosis, in these cases, was very poor. We reported a 30-year patient who, developing intramedullary and leptomeningeal metastases from GBM, underwent palliative spinal radiotherapy (RT) and Bevacizumab.
PMID: 22720749 [PubMed – indexed for MEDLINE]